Clinical Trials

NCT03632239 | ENROLLING_BY_INVITATION
1000 participants

Reverse Phenotyping Core

Study Type:
OBSERVATIONAL
Last Updated:
2026-06-01
Start Date:
2020-01-23
Completion:
2028-06-01
Conditions
  • Harboring of Unexpected Genetic Variant
No Results Yet
NCT03458936 | ACTIVE_NOT_RECRUITING
1500 participants

Resilience in Adolescent Development

Study Type:
OBSERVATIONAL
Last Updated:
2026-06-01
Start Date:
2016-08-17
Completion:
2031-12-31
Conditions
  • Risk Assessment
  • Resilience, Psychological
  • Depression
  • Mood Disorders
  • Anxiety Disorders
  • Mental Health
No Results Yet
NCT03257761 | ACTIVE_NOT_RECRUITING | PHASE1
55 participants

Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-01
Start Date:
2018-02-07
Completion:
2021-09-27
Conditions
  • Extrahepatic Bile Duct Adenocarcinoma, Biliary Type
  • Gallbladder Adenocarcinoma, Biliary Type
  • Metastatic Pancreatic Adenocarcinoma
  • Recurrent Cholangiocarcinoma
  • Recurrent Gallbladder Carcinoma
  • Recurrent Hepatocellular Carcinoma
  • Recurrent Intrahepatic Cholangiocarcinoma
  • Recurrent Pancreatic Carcinoma
  • Stage III Gallbladder Cancer AJCC V7
  • Stage III Hepatocellular Carcinoma AJCC v7
  • Stage III Intrahepatic Cholangiocarcinoma AJCC v7
  • Stage III Pancreatic Cancer AJCC v6 and v7
  • Stage IIIA Gallbladder Cancer AJCC v7
  • Stage IIIA Hepatocellular Carcinoma AJCC v7
  • Stage IIIB Gallbladder Cancer AJCC v7
  • Stage IIIB Hepatocellular Carcinoma AJCC v7
  • Stage IIIC Hepatocellular Carcinoma AJCC v7
  • Stage IV Gallbladder Cancer AJCC v7
  • Stage IV Hepatocellular Carcinoma AJCC v7
  • Stage IV Pancreatic Cancer AJCC v6 and v7
  • Stage IVA Gallbladder Cancer AJCC v7
  • Stage IVA Hepatocellular Carcinoma AJCC v7
  • Stage IVA Intrahepatic Cholangiocarcinoma AJCC v7
  • Stage IVB Gallbladder Cancer AJCC v7
  • Stage IVB Hepatocellular Carcinoma AJCC v7
  • Stage IVB Intrahepatic Cholangiocarcinoma AJCC v7
  • Unresectable Gallbladder Carcinoma
  • Unresectable Pancreatic Carcinoma
Interventions
  • BIOLOGICAL
  • DRUG
No Results Yet
NCT03213704 | ACTIVE_NOT_RECRUITING | PHASE2
9 participants

Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial)

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-01
Start Date:
2017-08-23
Completion:
2024-09-30
Conditions
  • Advanced Malignant Solid Neoplasm
  • Recurrent Ependymoma
  • Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor
  • Recurrent Glioma
  • Recurrent Hepatoblastoma
  • Recurrent Kidney Wilms Tumor
  • Recurrent Langerhans Cell Histiocytosis
  • Recurrent Malignant Germ Cell Tumor
  • Recurrent Malignant Glioma
  • Recurrent Malignant Solid Neoplasm
  • Recurrent Medulloblastoma
  • Recurrent Neuroblastoma
  • Recurrent Non-Hodgkin Lymphoma
  • Recurrent Osteosarcoma
  • Recurrent Rhabdoid Tumor
  • Recurrent Rhabdomyosarcoma
  • Recurrent Soft Tissue Sarcoma
  • Refractory Ependymoma
  • Refractory Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor
  • Refractory Glioma
  • Refractory Hepatoblastoma
  • Refractory Langerhans Cell Histiocytosis
  • Refractory Malignant Germ Cell Tumor
  • Refractory Malignant Glioma
  • Refractory Malignant Solid Neoplasm
  • Refractory Medulloblastoma
  • Refractory Neuroblastoma
  • Refractory Non-Hodgkin Lymphoma
  • Refractory Osteosarcoma
  • Refractory Primary Central Nervous System Neoplasm
  • Refractory Rhabdoid Tumor
  • Refractory Rhabdomyosarcoma
  • Refractory Soft Tissue Sarcoma
Interventions
  • PROCEDURE
  • DRUG
NCT03213002 | RECRUITING | PHASE1/PHASE2
67 participants

Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-01
Start Date:
2017-06-13
Completion:
2028-06-30
Conditions
  • Glioblastoma Multiforme (GBM)
  • Glioblastoma
  • Glioma of Brain
  • Glioblastoma, Adult
  • Brain Tumor
  • Brain Tumor, Primary
  • Brain Tumor Adult
  • Cancer
  • Brain Cancer
Interventions
  • DRUG
No Results Yet
NCT03210714 | ACTIVE_NOT_RECRUITING | PHASE2
20 participants

Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial)

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-01
Start Date:
2018-06-05
Completion:
2023-09-30
Conditions
  • Advanced Malignant Solid Neoplasm
  • Recurrent Childhood Ependymoma
  • Recurrent Childhood Malignant Germ Cell Tumor
  • Recurrent Childhood Medulloblastoma
  • Recurrent Childhood Non-Hodgkin Lymphoma
  • Recurrent Childhood Osteosarcoma
  • Recurrent Childhood Rhabdomyosarcoma
  • Recurrent Childhood Soft Tissue Sarcoma
  • Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor
  • Recurrent Hepatoblastoma
  • Recurrent Langerhans Cell Histiocytosis
  • Recurrent Malignant Glioma
  • Recurrent Malignant Solid Neoplasm
  • Recurrent Neuroblastoma
  • Recurrent Primary Central Nervous System Neoplasm
  • Recurrent Rhabdoid Tumor
  • Refractory Childhood Malignant Germ Cell Tumor
  • Refractory Childhood Osteosarcoma
  • Refractory Childhood Rhabdomyosarcoma
  • Refractory Childhood Soft Tissue Sarcoma
  • Refractory Ependymoma
  • Refractory Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor
  • Refractory Hepatoblastoma
  • Refractory Langerhans Cell Histiocytosis
  • Refractory Malignant Glioma
  • Refractory Malignant Solid Neoplasm
  • Refractory Medulloblastoma
  • Refractory Neuroblastoma
  • Refractory Non-Hodgkin Lymphoma
  • Refractory Primary Central Nervous System Neoplasm
  • Refractory Rhabdoid Tumor
  • Wilms Tumor
Interventions
  • PROCEDURE
  • DRUG
  • OTHER
NCT03206099 | RECRUITING
20000 participants

NIAID Centralized Sequencing Protocol

Study Type:
OBSERVATIONAL
Last Updated:
2026-06-01
Start Date:
2017-07-31
Completion:
2029-12-31
Conditions
  • Atopy
  • Primary Immunodeficiency
  • Autoimmunity
  • Autoinflammation
No Results Yet
NCT03155620 | ACTIVE_NOT_RECRUITING | PHASE2
1377 participants

Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-01
Start Date:
2017-07-31
Completion:
2025-03-31
Conditions
  • Advanced Malignant Solid Neoplasm
  • Ann Arbor Stage III Non-Hodgkin Lymphoma
  • Ann Arbor Stage IV Non-Hodgkin Lymphoma
  • Histiocytic Sarcoma
  • Juvenile Xanthogranuloma
  • Langerhans Cell Histiocytosis
  • Malignant Glioma
  • Recurrent Childhood Rhabdomyosarcoma
  • Recurrent Ependymoma
  • Recurrent Ewing Sarcoma
  • Recurrent Glioma
  • Recurrent Hepatoblastoma
  • Recurrent Langerhans Cell Histiocytosis
  • Recurrent Malignant Germ Cell Tumor
  • Recurrent Malignant Solid Neoplasm
  • Recurrent Medulloblastoma
  • Recurrent Neuroblastoma
  • Recurrent Non-Hodgkin Lymphoma
  • Recurrent Osteosarcoma
  • Recurrent Peripheral Primitive Neuroectodermal Tumor
  • Recurrent Primary Central Nervous System Neoplasm
  • Recurrent Rhabdoid Tumor
  • Recurrent Soft Tissue Sarcoma
  • Refractory Ewing Sarcoma
  • Refractory Glioma
  • Refractory Hepatoblastoma
  • Refractory Langerhans Cell Histiocytosis
  • Refractory Malignant Germ Cell Tumor
  • Refractory Malignant Solid Neoplasm
  • Refractory Medulloblastoma
  • Refractory Neuroblastoma
  • Refractory Non-Hodgkin Lymphoma
  • Refractory Osteosarcoma
  • Refractory Peripheral Primitive Neuroectodermal Tumor
  • Refractory Primary Central Nervous System Neoplasm
  • Refractory Rhabdoid Tumor
  • Refractory Rhabdomyosarcoma
  • Rhabdoid Tumor
  • Stage III Osteosarcoma AJCC v7
  • Stage III Soft Tissue Sarcoma AJCC v7
  • Stage IV Osteosarcoma AJCC v7
  • Stage IV Soft Tissue Sarcoma AJCC v7
  • Stage IVA Osteosarcoma AJCC v7
  • Stage IVB Osteosarcoma AJCC v7
  • Wilms Tumor
Interventions
  • PROCEDURE
  • DRUG
  • OTHER
NCT03148743 | RECRUITING
50 participants

FMT in Gut aGVHD Treated

Study Type:
OBSERVATIONAL
Last Updated:
2026-06-01
Start Date:
2017-05-16
Completion:
2028-12-01
Conditions
  • Acute-graft-versus-host Disease
Interventions
  • BIOLOGICAL
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page